How do you calculate Immunoscore? A tour of HalioDx
Audio Slideshow tour of HalioDx lab that shows how digital pathology is used to calculate Immunoscore an immune based colon cancer assay
October 3, 2016
Manipulating the Microbiota to Improve Clinical Outcomes. An interview with Eric Pamer
Interview with Dr Eric Pamer on impact of the microbiota on the innate and adaptive immune systems and future directions.
September 28, 2016
Is Targeting Neoantigens the Next Frontier in Cancer Immunotherapy?
Interview with Prof Ton Schumacher at scientific meeting to celebrate 40 years of Centre d’Immunologie de Marseille-Luminy (CIML).
September 22, 2016
François Romagné Accelerates Cancer Immunotherapy Innovation in Marseille
Interview with Professor François Romagné, Scientific Director of MI-mAbs, an immuno-oncology drug discovery venture in the Marseille Immunopôle cluster.
September 21, 2016
Innate Pharma at an Inflexion Point: An interview with CEO Hervé Brailly
Interview with Innate Pharma CEO Dr Hervé Brailly on clinical trial readouts expected and his vision for company
September 20, 2016
Why target the Innate Immune system? An interview with Eric Vivier
Professor Eric Vivier is Director of the Centre d’Immunologie de Marseille-Luminy and a co-founder of Innate Pharma and the Marseille Immunopôle. He is a leading researcher in the field of innate immunity.
September 19, 2016
HalioDX CEO Vincent Fert outlines commercial strategy for Immunoscore in US and Europe
Interview with HalioDx CEO Vincent Fert on commercial strategy for Immunoscore diagnostic test.
September 14, 2016